Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity

被引:256
作者
Enomoto, A
Takeda, M
Tojo, A
Sekine, T
Cha, SH
Khamdang, S
Takayama, F
Aoyama, I
Nakamura, S
Endou, H
Niwa, T
机构
[1] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan
[2] Nagoya Univ, Sch Med, Dept Clin Prevent Med, Nagoya, Aichi 466, Japan
[3] Univ Tokyo, Dept Pediat, Tokyo 113, Japan
[4] Univ Tokyo, Dept Nephrol & Endocrinol, Tokyo 113, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 07期
关键词
D O I
10.1097/01.ASN.0000022017.96399.B2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In uremic patients, various uremic toxins are accumulated and exert various biologic effects on uremia. Indoxyl sulfate (IS) is one of uremic toxins that is derived from dietary protein, and serum levels of IS are markedly increased in both uremic rats and patients. It has been previously reported that the accumulation of IS promotes the progression of chronic renal failure (CRF). This study demonstrates the role of rat organic anion transporters (rOATs) in the transport of IS and the induction of its nephrotoxicity. The administration of IS to 5/6-nephrectomized rats caused a faster progression of CRF, and immunohistochemistry revealed that IS was detected in the proximal and distal tubules where rOAT1 (proximal tubules) and/or rOAT3 (proximal and distal tubules) were also shown to be localized. In in vitro study, the proximal tubular cells derived from mouse that stably express rOAT1 (S2 rOAT1) and rOAT3 (S2 rOAT3) were established. IS inhibited organic anion uptake by S2 rOAT1 and S2 rOAT3, and the Ki values were 34.2 and 74.4 muM, respectively. Compared with mock, S2 rOAT1 and S2 rOAT3 exhibited higher levels of IS uptake, which was inhibited by probenecid and cilastatin, organic anion transport inhibitors. The addition of IS induced a decrease in the viability of S2 rOAT1 and S2 rOAT3 as compared with the mock, which was rescued by probenecid. These results suggest that rOAT1 and rOAT3 play an important role in the transcellular transport of IS and the induction of its nephrotoxicity.
引用
收藏
页码:1711 / 1720
页数:10
相关论文
共 50 条
  • [11] FOLLENIUS M, 1982, J CLIN ENDOCR METAB, V55, P757, DOI 10.1210/jcem-55-4-757
  • [12] Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions
    Hasegawa, M
    Kusuhara, H
    Sugiyama, D
    Ito, K
    Ueda, S
    Endou, H
    Sugiyama, Y
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) : 746 - 753
  • [13] Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene
    Hosoyamada, M
    Obinata, M
    Suzuki, M
    Endou, H
    [J]. ARCHIVES OF TOXICOLOGY, 1996, 70 (05) : 284 - 292
  • [14] HOSOYAMADA M, 1999, AM J PHYSIOL, V45, pF122
  • [15] EXPRESSION CLONING OF A RAT-LIVER NA+-INDEPENDENT ORGANIC ANION TRANSPORTER
    JACQUEMIN, E
    HAGENBUCH, B
    STIEGER, B
    WOLKOFF, AW
    MEIER, PJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) : 133 - 137
  • [16] Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: In comparison with rOAT1
    Jung, KY
    Takeda, M
    Shimoda, M
    Narikawa, S
    Tojo, A
    Kim, DK
    Chairoungdua, A
    Choi, BK
    Kusuhara, H
    Sugiyama, Y
    Sekine, T
    Endou, H
    [J]. LIFE SCIENCES, 2002, 70 (16) : 1861 - 1874
  • [17] KELLY CJ, 2000, KIDNEY, P1509
  • [18] ROLE OF DIETARY FACTORS IN THE PROGRESSION OF CHRONIC RENAL-DISEASE
    KLAHR, S
    BUERKERT, J
    PURKERSON, ML
    [J]. KIDNEY INTERNATIONAL, 1983, 24 (05) : 579 - 587
  • [19] KLAHR S, 1988, NEW ENGL J MED, V318, P1657
  • [20] THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE
    KLAHR, S
    LEVEY, AS
    BECK, GJ
    CAGGIULA, AW
    HUNSICKER, L
    KUSEK, JW
    STRIKER, G
    BUCKALEW, V
    BURKART, J
    FURBERG, C
    FELTS, J
    MOORE, M
    ROCCO, H
    DOLECEK, T
    WARREN, S
    BEARDEN, B
    STARKEY, C
    HARVEY, J
    POOLE, D
    DAHLQUIST, S
    DOROSHENKO, L
    BRADHAM, K
    WEST, D
    AGOSTINO, J
    COLE, L
    BAKER, B
    HAIRSTON, K
    BURGOYNE, S
    LAZARUS, J
    STEINMAN, T
    SEIFTER, J
    DESMOND, M
    FIORENZO, M
    CHIAVACCI, A
    METALIDES, T
    KORZECRAMIREZ, D
    GOULD, S
    PICKETT, V
    PORUSH, J
    FAUBERT, P
    SPITALEWITZ, S
    FAUBERT, J
    ZIMMER, G
    SAUM, D
    BLOCK, M
    WOEL, J
    ROSE, M
    DENNIS, V
    SCHWAB, S
    MINDA, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) : 877 - 884